TY - JOUR
T1 - Abrogation of ionizing radiation-induced G2 checkpoint and inhibition of nuclear export by Cryptocarya pyrones
AU - Sturgeon, Christopher M.
AU - Cinel, Bruno
AU - Díaz-Marrero, Ana R.
AU - McHardy, Lianne M.
AU - Ngo, Michelle
AU - Andersen, Raymond J.
AU - Roberge, Michel
N1 - Funding Information:
Acknowledgments We thank G. Cragg and D. Newman for access to the NCI Natural Products Repository and H. Anderson for helpful discussions. This work was supported by grants from the National Cancer Institute of Canada with funds from the Canadian Cancer Society (MR and RJA).
PY - 2008/3
Y1 - 2008/3
N2 - G2 checkpoint inhibitors can force cells arrested in G 2 phase by DNA damage to enter mitosis. In this manner, several G2 checkpoint inhibitors can enhance killing of cancer cells by ionizing radiation and DNA-damaging chemotherapeutic agents, particularly in cells lacking p53 function. All G2 checkpoint inhibitors identified to date target protein phosphorylation by inhibiting checkpoint kinases or phosphatases. Using a phenotypic cell-based assay for G2 checkpoint inhibitors, we have screened a large collection of plant extracts and identified Z-Cryptofolione and Cryptomoscatone D2 as highly efficacious inhibitors of the G2 checkpoint. These compounds and related pyrones also inhibit nuclear export. Leptomycin B, a potent inhibitor of Crm1-mediated nuclear export, is also a very potent G2 checkpoint inhibitor. These compounds possess a reactive Michael acceptor site and do not appear promising as a radiosensitizing agents because they are toxic to unirradiated cells at checkpoint inhibitory concentrations. Nevertheless, the results show that inhibition of nuclear export is an alternative to checkpoint kinase inhibition for abrogating the G2 checkpoint and they should stimulate the search for less toxic nuclear export inhibitors.
AB - G2 checkpoint inhibitors can force cells arrested in G 2 phase by DNA damage to enter mitosis. In this manner, several G2 checkpoint inhibitors can enhance killing of cancer cells by ionizing radiation and DNA-damaging chemotherapeutic agents, particularly in cells lacking p53 function. All G2 checkpoint inhibitors identified to date target protein phosphorylation by inhibiting checkpoint kinases or phosphatases. Using a phenotypic cell-based assay for G2 checkpoint inhibitors, we have screened a large collection of plant extracts and identified Z-Cryptofolione and Cryptomoscatone D2 as highly efficacious inhibitors of the G2 checkpoint. These compounds and related pyrones also inhibit nuclear export. Leptomycin B, a potent inhibitor of Crm1-mediated nuclear export, is also a very potent G2 checkpoint inhibitor. These compounds possess a reactive Michael acceptor site and do not appear promising as a radiosensitizing agents because they are toxic to unirradiated cells at checkpoint inhibitory concentrations. Nevertheless, the results show that inhibition of nuclear export is an alternative to checkpoint kinase inhibition for abrogating the G2 checkpoint and they should stimulate the search for less toxic nuclear export inhibitors.
KW - Checkpoint inhibitor
KW - DNA damage
KW - Leptomycin B
KW - Nuclear export
KW - Z-Cryptofolione
UR - http://www.scopus.com/inward/record.url?scp=37249083061&partnerID=8YFLogxK
U2 - 10.1007/s00280-007-0483-y
DO - 10.1007/s00280-007-0483-y
M3 - Article
C2 - 17440726
AN - SCOPUS:37249083061
SN - 0344-5704
VL - 61
SP - 407
EP - 413
JO - Cancer Chemotherapy and Pharmacology
JF - Cancer Chemotherapy and Pharmacology
IS - 3
ER -